Jacobs Levy Equity Management’s Nu Skin NUS Stock Holding History

Jacobs Levy Equity Management’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$804K	Buy	+152,195	New	+$973K	﹤0.01%	746
2025 Q1	–	Sell	-51,323	Closed	-$354K	–	1160
2024 Q4	$354K	Sell	51,323 -2,395	-4%	-$16.5K	﹤0.01%	857
2024 Q3	$396K	Sell	53,718 -263,870	-83%	-$2.47M	﹤0.01%	861
2024 Q2	$3.35M	Buy	317,588 +34,233	+12%	+$434K	0.01%	508
2024 Q1	$3.92M	Buy	283,355 +181,528	+178%	+$2.83M	0.02%	474
2023 Q4	$1.98M	Buy	+101,827	New	+$1.88M	0.01%	605
2022 Q3	–	Sell	-105,881	Closed	-$4.58M	–	1114
2022 Q2	$4.58M	Sell	105,881 -24,921	-19%	-$1.14M	0.04%	432
2022 Q1	$6.26M	Buy	130,802 +20,690	+19%	+$1.03M	0.04%	376
2021 Q4	$5.59M	Buy	+110,112	New	+$4.89M	0.04%	405
2020 Q1	–	Sell	-53,096	Closed	-$2.18M	–	1063
2019 Q4	$2.18M	Buy	53,096 +5,406	+11%	+$221K	0.02%	526
2019 Q3	$2.03M	Sell	47,690 -65,915	-58%	-$2.77M	0.02%	505
2019 Q2	$5.6M	Sell	113,605 -104,449	-48%	-$5.31M	0.08%	319
2019 Q1	$10.4M	Buy	218,054 +68,475	+46%	+$4.15M	0.15%	176
2018 Q4	$9.17M	Buy	149,579 +58,341	+64%	+$3.94M	0.16%	151
2018 Q3	$7.52M	Buy	91,238 +9,675	+12%	+$769K	0.11%	226
2018 Q2	$6.38M	Sell	81,563 -27,270	-25%	-$2.11M	0.1%	251
2018 Q1	$8.02M	Buy	108,833 +9,120	+9%	+$647K	0.13%	208
2017 Q4	$6.8M	Buy	+99,713	New	+$6.45M	0.12%	226
2017 Q3	–	Sell	-11,400	Closed	-$716K	–	1005
2017 Q2	$716K	Sell	11,400 -58,970	-84%	-$3.36M	0.02%	623
2017 Q1	$3.91M	Sell	70,370 -58,476	-45%	-$3.01M	0.08%	297
2016 Q4	$6.16M	Sell	128,846 -24,540	-16%	-$1.37M	0.12%	228
2016 Q3	$9.94M	Buy	+153,386	New	+$8.62M	0.18%	165
2014 Q2	–	Sell	-116,406	Closed	-$9.64M	–	898
2014 Q1	$9.64M	Sell	116,406 -170,140	-59%	-$14.9M	0.16%	175
2013 Q4	$39.6M	Buy	286,546 +66,906	+30%	+$7.88M	0.6%	34
2013 Q3	$21M	Buy	219,640 +186,690	+567%	+$15.8M	0.36%	83
2013 Q2	$2.01M	Buy	+32,950	New	+$1.83M	0.04%	416

Other funds holding NUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Jacobs Levy Equity Management's NUS Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Nu Skin (NUS) in Q2 2026: 152,195 shares worth $804K. The stake represents ﹤0.01% of the portfolio and ranks #746 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in NUS as recently as Q4 2024.

Jacobs Levy Equity Management first reported a position in NUS in Q2 2013 and has held it in 26 quarters since. The position peaked at $39.6M in Q4 2013. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

Jacobs Levy Equity Management held 152,195 shares of Nu Skin worth $804K as of Q2 2026.
Nu Skin was a new Jacobs Levy Equity Management position in Q2 2026.
Nu Skin made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #746 holding.
Jacobs Levy Equity Management first reported a position in Nu Skin in Q2 2013 and has held it in 26 quarters since.
Jacobs Levy Equity Management's Nu Skin position peaked at $39.6M in Q4 2013.
162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.